POTENTIAL INHIBITORS OF L-ASPARAGINE BIOSYNTHESIS .3. AROMATIC SULFONYL FLUORIDE ANALOGS OF L-ASPARAGINE AND L-GLUTAMINE

被引：6

作者：

MOKOTOFF, M ^{[1
]}

BRYNES, S ^{[1
]}

BAGAGLIO, JF ^{[1
]}

机构：

[1] UNIV PITTSBURGH,SCH PHARM,DEPT MED CHEM,PITTSBURGH,PA 15261

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1975年 / 18卷 / 09期

关键词：

D O I：

10.1021/jm00243a005

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：888 / 891

页数：4

共 24 条

[1] IRREVERSIBLE ENZYME INHIBITORS .105. DIFFERENTIAL IRREVERSIBLE INHIBITION OF VERTEBRATE DIHYDROFOLIC REDUCTASES BY DERIVATIVES OF 4,6-DIAMINO-1,2-DIHYDRO-2,2-DIMETHYL-1-PHENYL-S-TRIAZINES SUBSTITUTED WITH A TERMINAL SULFONYL FLUORIDE [J].

BAKER, BR ;

LOURENS, GJ .

JOURNAL OF MEDICINAL CHEMISTRY, 1967, 10 (06) :1113-+

[2] IRREVERSIBLE ENZYME INHIBITORS .185. ACTIVE-SITE-DIRECTED IRREVERSIBLE INHIBITORS OF GUANINE DEAMINASE DERIVED FROM 9-PHENYLGUANINE BEARING A TERMINAL SULFONYL FLUORIDE .2. [J].

BAKER, BR ;

SIEBENEICK, HU .

JOURNAL OF MEDICINAL CHEMISTRY, 1971, 14 (09) :802-+

[3]

BARZILAY I, 1956, B RES COUNC ISRAEL A, V5, P155

[4] FORMATION OF ASPARAGINE FROM ASPARTIC ACID IN RAT BRAIN [J].

BENUCK, M ;

STERN, F ;

LAJTHA, A .

JOURNAL OF NEUROCHEMISTRY, 1970, 17 (08) :1133-+

[5] DIFFERENCES IN PRODUCTION OF L-ASPARAGINE IN ASPARAGINASE-SENSITIVE AND RESISTANT LYMPHOMA CELLS [J].

BROOME, JD ;

SCHWARTZ, JH .

BIOCHIMICA ET BIOPHYSICA ACTA, 1967, 138 (03) :637-&

[6] STUDIES ON MECHANISM OF TUMOR INHIBITION BY L-ASPARAGINASE - EFFECTS OF ENZYME ON ASPARAGINE LEVELS IN BLOOD NORMAL TISSUES AND 6C3HED LYMPHOMAS OF MICE - DIFFERENCES IN ASPARAGINE FORMATION AND UTILIZATION IN ASPARAGINASE-SENSITIVE AND -RESISTANT LYMPHOMA CELLS [J].

BROOME, JD .

JOURNAL OF EXPERIMENTAL MEDICINE, 1968, 127 (06) :1055-&

[7] PRODUCTION OF L-ASPARAGINE BY TUMOR-CELLS AND EFFECT OF ASPARAGINE ANALOGS [J].

CHOU, TC ;

HANDSCHUMACHER, RE .

BIOCHEMICAL PHARMACOLOGY, 1972, 21 (01) :39-+

[8] L-ASPARAGINASE RESISTANCE IN HUMAN LEUKEMIA - AS PARAGINE SYNTHETASE [J].

HASKELL, CM ;

CANELLOS, GP .

BIOCHEMICAL PHARMACOLOGY, 1969, 18 (10) :2578-&

[9]

HASKELL CM, 1970, CANCER RES, V30, P1081

[10]

HOROWITZ B, 1972, J BIOL CHEM, V247, P6708

← 1 2 3 →